今年6月7日,渤健(Biogen)基于β-淀粉样蛋白假说而开发的第一款用于治疗AD的单克隆抗体药物Aduhelm历经波折,终获得美国FDA批准上市,是近20年来AD领域首款新疗法...查看全文
$Trident(TDAC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-20-011280 Act: 34 Size: 1 MB 网页链接
$Trident(TDAC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001213900-20-011058 Act: 34 Size: 184 KB 网页链接
$Trident(TDAC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000905148-20-000479 Act: 34 Size: 195 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001393825-20-000107 Act: 34 Size: 57 KB 网页链接
$Trident(TDAC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001393825-20-000098 Size: 6 KB 网页链接
$Trident(TDAC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-20-006552 Act: 34 Size: 3 MB 网页链接
$Trident(TDAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-006164 Size: 4 KB 网页链接
$Trident(TDAC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-20-006146 Size: 5 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001076809-20-000015 Act: 34 Size: 59 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000904454-20-000186 Act: 34 Size: 59 KB 网页链接